Since the importance of EGFR amplification has already been established as a precision medicine target in other cancers, such as colorectal cancers, HNSCC, and NSCLC [11], our findings may also open new therapeutic approaches in future brain tumor therapy [30,31]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.